Separation, culture and purification methods of human amniotic mesenchymal stem cells

A technology of mesenchymal stem cells and separation methods, applied in the field of culture and purification, and separation of human amniotic mesenchymal stem cells, can solve problems such as damaged tissues and cells, impaired activity of amniotic mesenchymal stem cells, and incomplete removal of epithelial cells, etc., to achieve The effect of increasing the growth rate

Inactive Publication Date: 2018-11-23
GUANGDONG VITALIFE BIOTECHNOLOGY CO LTD
View PDF6 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Most of the existing amnion epithelial cells are separated by trypsin digestion, which can remove most of the amnion epithelial cells, but the removal of epithelial cells is not complete, and they will still affect each other during normal culture, and trypsin is a broad-spectrum protein Digestive enzymes, the digestion process will cause great damage to the cells. It is difficult to accurately grasp the concentration of trypsin, digestion conditions and digestion time. If the enzyme concentration is too high or the digestion time is slightly longer, the tissue and cells may be seriously damaged, resulting in the activity of the isolated amniotic mesenchymal stem cells. Damaged, affecting later use

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Separation, culture and purification methods of human amniotic mesenchymal stem cells
  • Separation, culture and purification methods of human amniotic mesenchymal stem cells
  • Separation, culture and purification methods of human amniotic mesenchymal stem cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0030] The technical solutions of the present invention will be described in further detail below in conjunction with specific examples, but the present invention is not limited to the following examples.

[0031] Isolate, culture and purify human amniotic mesenchymal stem cells, the steps are as follows:

[0032] 1. The hospital collects full-term cesarean section human fetal placenta tissue, signs the client's informed consent before collection, and transports the tissue to the laboratory in a refrigerated and sterile environment at 4°C. During transportation, the tissue protection solution is used to protect the biological activity of the placenta tissue and protect the tissue. The solution is prepared by adding 25 μg / ml gentamicin sulfate and 5 μg / ml amphotericin B to normal saline to ensure no bacterial and fungal contamination during transportation;

[0033] 2. Isolate the amniotic membrane tissue in the sterile laboratory, wash the amniotic membrane tissue 2-3 times wit...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
thicknessaaaaaaaaaa
Login to view more

Abstract

The invention provides a separation method of human amniotic mesenchymal stem cells. The separation method comprises the following steps: (1) collecting human placental tissues and separating amniotictissues; washing blood stains; (2) chopping the amniotic tissues and adding a first tissue digestion solution and carrying out digestion; (3) after finishing the digestion, removing the first tissuedigestion solution; washing the amniotic tissues; adding a second tissue digestion solution and carrying out digestion; (4) after finishing the digestion, adding a trypsin solution and carrying out digestion; (5) adding a stop solution and stopping the digestion; filtering to remove tissue blocks which are completely digested, collecting a cell suspension solution and centrifuging; (6) removing supernatant, adding a DMEM (Dulbecco's Modified Eagle Medium) and washing sediment; centrifuging again to obtain the separated human amniotic mesenchymal stem cells. The method provided by the inventionis simple and effective, can obtain high-purity human amniotic mesenchymal stem cells and has no influences on cell activity.

Description

technical field [0001] The invention belongs to the field of stem cells and regenerative medicine, in particular to a method for separating, cultivating and purifying human amniotic mesenchymal stem cells. Background technique [0002] Mesenchymal stem cells (MSCs) are a type of pluripotent stem cells derived from mesoderm with high self-renewal and multi-directional differentiation capabilities. They can be cultured and expanded in vitro and have multi-directional differentiation capabilities under specific conditions, and can differentiate into fat. Cells, chondrocytes, bone cells, liver cells, and even laterally differentiate into nerve cells, epidermal cells, etc. MSCs have broad clinical application prospects and are the most important seed cells in the fields of regenerative medicine and tissue engineering. [0003] Mesenchymal stem cells were first discovered in bone marrow tissue. With the deepening of research, they have also been found in various tissues of the hum...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0775
CPCC12N5/0668C12N2509/00
Inventor 朱建斌江嘉豪何美第陈炽峰康斯敏陈碧莹蔡祥胜王明珠王进辉
Owner GUANGDONG VITALIFE BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products